A Review on Comprehensive Therapy of Ascites Cancer

Authors

  • Manpreet Arora
  • Madan L. Kaushik

DOI:

https://doi.org/10.37591/rrjomv.v8i1.40

Abstract

Ascites cancer is a condition in which there is a fluid accumulation in the peritoneal cavity due to diseases like liver disease, heart failure, renal disease and malignancy. Approximately 50% of all cirrhotic patients develop ascites cancer every year. The average survival after development of malignant ascites is only about 5 months. The most common symptoms of Ascites are recent weight gain, increased abdominal girth and dyspnoea. The development of ascites leads to significant symptoms and poor quality of life for the cancer patient. There are many potential causes of ascites in cancer patients, including peritoneal carcinomatosis, portal vein thrombosis, elevated portal venous pressure, congestive heart failure, nephrotic syndrome and peritoneal infections. The first line treatment of ascites includes education regarding dietary sodium restriction and oral diuretics. A guideline on the management of symptomatic malignant ascites by abdominal paracentesis, diuretics and peritoneovenous shunting, based on the review of this literature is presented. This review is intended to add clarity and valuable treatments to the current procedures for the management of malignant ascites and furthermore discusses new promising approaches.

Keywords: Peritoneal cancer, carcinoma, diuretics, portal vein thrombosis

Cite this Article Manpreet Arora, Kaushik Madan L. A Review on Comprehensive Therapy of Ascites Cancer. Research & Reviews: A Journal of Microbiology and Virology. 2018; 8(1): 1–6p. 

Downloads

Published

2018-03-05

Issue

Vol. 8 No. 1 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.